Iradimed (IRMD) Operating Leases (2019 - 2024)

Iradimed (IRMD) has 6 years of Operating Leases data on file, last reported at $2000.0 in Q4 2024.

• Quarterly Operating Leases fell 99.88% year-over-year to $2000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2000.0 (down 99.88% YoY) and the FY2024 annual result came in at $2000.0, down 99.88% from the prior year.
• Operating Leases eased to $2000.0 in Q4 2024 per IRMD's latest filing, from $2831.0 in the prior quarter.
• Across five years, Operating Leases topped out at $2.7 million in Q1 2020 and bottomed at $2000.0 in Q4 2024.
• The 5-year median for Operating Leases is $2.0 million (2022), against an average of $1.8 million.
• The widest annual swing landed in 2020, when Operating Leases fell 8.44%; it then sank 99.88% in 2024.
• Tracing IRMD's Operating Leases over 5 years: stood at $2.5 million in 2020, then declined by 10.32% to $2.2 million in 2021, then dropped by 13.32% to $1.9 million in 2022, then retreated by 15.52% to $1.6 million in 2023, then slumped by 99.88% to $2000.0 in 2024.
• Per Business Quant, the three latest IRMD Operating Leases figures stand at $2000.0 (Q4 2024), $2831.0 (Q3 2024), and $4231.0 (Q2 2024).

Peer Comparison